For example, interleukin-22 (IL-22), a member of the IL-20 subfamily, controls lipid metabolism in the liver via activation of the STAT3 signaling pathway and, consequently, reduces fatty liver disease (4). This evidence concerns the gene IL22 and fatty liver disease.